These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37702275)

  • 61. Current and emerging drugs for interstitial cystitis/bladder pain syndrome (IC/BPS).
    Ogawa T; Ishizuka O; Ueda T; Tyagi P; Chancellor MB; Yoshimura N
    Expert Opin Emerg Drugs; 2015; 20(4):555-70. PubMed ID: 26535808
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis.
    Chiu B; Tai HC; Chung SD; Birder LA
    Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376330
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome.
    Mohammad A; Laboulaye MA; Shenhar C; Dobberfuhl AD
    Nat Rev Urol; 2024 Jul; 21(7):433-449. PubMed ID: 38326514
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interstitial cystitis/bladder pain syndrome (IC/BPS): Single-center 20 year experience and treatment results in India.
    Mishra NN
    Neurourol Urodyn; 2022 Aug; 41(6):1390-1398. PubMed ID: 35598079
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intravesical Administration of Xenogeneic Porcine Urothelial Cells Attenuates Cyclophosphamide-Induced Cystitis in Mice.
    Huang CP; Chen CC; Tsai YT; Wu CC; Shyr CR
    Cell Transplant; 2019 Mar; 28(3):296-305. PubMed ID: 30675801
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Hanno P; Kumar K; Thomas H
    Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preliminary study on urinary cytokine levels in interstitial cystitis: does intravesical bacille Calmette-Guérin treat interstitial cystitis by altering the immune profile in the bladder?
    Peters KM; Diokno AC; Steinert BW
    Urology; 1999 Sep; 54(3):450-3. PubMed ID: 10475352
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome.
    Liu HT; Shie JH; Chen SH; Wang YS; Kuo HC
    Urology; 2012 Jul; 80(1):225.e13-8. PubMed ID: 22521193
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation.
    Taidi Z; Mansfield KJ; Bates L; Sana-Ur-Rehman H; Liu L
    Bladder (San Franc); 2019; 6(1):e38. PubMed ID: 32775480
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of key genes in human urothelial cells corresponding to interstitial cystitis/bladder pain syndrome in a lipopolysaccharide-induced cystitis model.
    Peng L; Li BY; Wang W; Gao XS; Zeng X; Luo DY
    Neurourol Urodyn; 2021 Sep; 40(7):1720-1729. PubMed ID: 34245600
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Broaden Horizons: The Advancement of Interstitial Cystitis/Bladder Pain Syndrome.
    Li J; Yi X; Ai J
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498919
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
    Wang X; Liu W; O'Donnell M; Lutgendorf S; Bradley C; Schrepf A; Liu L; Kreder K; Luo Y
    PLoS One; 2016; 11(12):e0168772. PubMed ID: 28002455
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
    Jhang JF; Jiang YH; Kuo HC
    Int J Urol; 2014 Apr; 21 Suppl 1():49-55. PubMed ID: 24807497
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular determinants of afferent sensitization in a rat model of cystitis with urothelial barrier dysfunction.
    Montalbetti N; Rooney JG; Rued AC; Carattino MD
    J Neurophysiol; 2019 Sep; 122(3):1136-1146. PubMed ID: 31314637
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
    Jhang JF; Hsu YH; Kuo HC
    Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis.
    Barua JM; Arance I; Angulo JC; Riedl CR
    Int Urogynecol J; 2016 Aug; 27(8):1137-47. PubMed ID: 26590137
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intravesical treatments of bladder pain syndrome/interstitial cystitis.
    Neuhaus J; Schwalenberg T
    Nat Rev Urol; 2012 Dec; 9(12):707-20. PubMed ID: 23183946
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
    Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
    Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative safety review of current pharmacological treatments for interstitial cystitis/ bladder pain syndrome.
    Chen PY; Lee WC; Chuang YC
    Expert Opin Drug Saf; 2021 Sep; 20(9):1049-1059. PubMed ID: 33944647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.